Takayasu 	Takayasu 	 NNP	O
's  	's  	 POS	O
arteritis  	arteritis  	 NN	B-NP
in  	in  	 IN	O
Turkey  	Turkey  	 NNP	O
-  	-  	 :	O
clinical  	clinical  	 JJ	O
and  	and  	 CC	O
angiographic  	angiographic  	 JJ	B-NP
features  	features  	 NNS	I-NP
of  	of  	 IN	O
248  	248  	 CD	O
patients  	patients  	 NNS	O
Takayasu 	Takayasu 	 NNP	O
's  	's  	 POS	O
arteritis  	arteritis  	 NN	B-NP
( 	( 	 -LRB-	O
TA 	TA 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
a  	a  	 DT	O
chronic 	chronic 	 NN	O
,  	,  	 ,	O
inflammatory  	inflammatory  	 JJ	B-NP
vasculitis  	vasculitis  	 NNS	I-NP
affecting  	affecting  	 VBG	O
the  	the  	 DT	O
aorta  	aorta  	 NN	B-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
major  	major  	 JJ	O
branches 	branches 	 NNS	O
.  	.  	 .	O
Although  	Although  	 IN	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
more  	more  	 RBR	O
prevalent  	prevalent  	 JJ	O
in  	in  	 IN	O
Far-East  	Far-East  	 NNP	O
Asia 	Asia 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
distribution  	distribution  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
disease  	disease  	 NN	O
is  	is  	 VBZ	O
worldwide  	worldwide  	 VBN	O
with  	with  	 IN	O
different  	different  	 JJ	O
vascular  	vascular  	 JJ	B-NP
involvement  	involvement  	 NN	I-NP
patterns  	patterns  	 NNS	I-NP
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
manifestations 	manifestations 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
objective  	objective  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
demographic 	demographic 	 JJ	B-NP
,  	,  	 ,	O
clinical 	clinical 	 JJ	O
,  	,  	 ,	O
angiographic  	angiographic  	 NN	B-NP
and  	and  	 CC	O
prognostic  	prognostic  	 JJ	B-NP
features  	features  	 NNS	I-NP
of  	of  	 IN	I-NP
TA  	TA  	 NNP	I-NP
patients  	patients  	 NNS	I-NP
in  	in  	 IN	O
Turkey 	Turkey 	 NNP	O
.  	.  	 .	O
Clinical  	Clinical  	 JJ	O
and  	and  	 CC	O
angiographic  	angiographic  	 JJ	B-NP
findings  	findings  	 NNS	I-NP
of  	of  	 IN	O
248  	248  	 CD	O
TA  	TA  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
( 	( 	 -LRB-	O
228  	228  	 CD	O
female 	female 	 NN	O
,  	,  	 ,	O
27  	27  	 CD	O
male 	male 	 NN	O
)  	)  	 -RRB-	O
followed  	followed  	 VBD	O
at  	at  	 IN	O
15  	15  	 CD	O
Rheumatology  	Rheumatology  	 NNP	O
Centers  	Centers  	 NNPS	O
were  	were  	 VBD	O
prospectively  	prospectively  	 RB	O
evaluated  	evaluated  	 VBN	O
according  	according  	 VBG	O
to  	to  	 TO	O
a  	a  	 DT	O
predefined  	predefined  	 JJ	B-NP
protocol 	protocol 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
mean  	mean  	 JJ	O
age  	age  	 NN	O
was  	was  	 VBD	O
40.1  	40.1  	 CD	O
years  	years  	 NNS	O
( 	( 	 -LRB-	O
30.2  	30.2  	 CD	O
years  	years  	 NNS	O
at  	at  	 IN	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
onset 	onset 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Clinical  	Clinical  	 JJ	B-NP
manifestations  	manifestations  	 NNS	I-NP
included  	included  	 VBD	O
constitutional  	constitutional  	 JJ	B-NP
symptoms  	symptoms  	 NNS	I-NP
in  	in  	 IN	O
66 	66 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
absent  	absent  	 JJ	O
or  	or  	 CC	O
diminished  	diminished  	 JJ	O
pulses  	pulses  	 NN	O
in  	in  	 IN	O
88 	88 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
bruits  	bruits  	 VBG	O
in  	in  	 IN	O
77 	77 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
extremity  	extremity  	 JJ	B-NP
pain  	pain  	 NN	I-NP
in  	in  	 IN	O
69 	69 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
claudication  	claudication  	 NN	B-NP
in  	in  	 IN	O
48 	48 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
hypertension  	hypertension  	 NN	O
in  	in  	 IN	O
43 	43 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
cerebrovascular  	cerebrovascular  	 JJ	B-NP
accidents  	accidents  	 NNS	I-NP
( 	( 	 -LRB-	O
CVA 	CVA 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
18 	18 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
patients 	patients 	 NNS	O
.  	.  	 .	O
Renal  	Renal  	 JJ	B-NP
artery  	artery  	 NN	I-NP
stenosis 	stenosis 	 NN	I-NP
,  	,  	 ,	O
aortic  	aortic  	 JJ	B-NP
regurgitation  	regurgitation  	 NN	I-NP
and  	and  	 CC	O
pulmonary  	pulmonary  	 JJ	B-NP
hypertension  	hypertension  	 NN	I-NP
were  	were  	 VBD	O
present  	present  	 JJ	O
in  	in  	 IN	O
26 	26 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
33 	33 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
12 	12 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
According  	According  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
new  	new  	 JJ	O
angiographic  	angiographic  	 JJ	B-NP
classification 	classification 	 NN	I-NP
,  	,  	 ,	O
type  	type  	 NN	O
V  	V  	 NNP	O
( 	( 	 -LRB-	O
50.8 	50.8 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
Type  	Type  	 NNP	O
I  	I  	 NNP	O
( 	( 	 -LRB-	O
32 	32 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
the  	the  	 DT	O
most  	most  	 RBS	O
frequent  	frequent  	 JJ	O
types  	types  	 NNS	O
of  	of  	 IN	O
involvement 	involvement 	 NN	O
.  	.  	 .	O
Corticosteroids  	Corticosteroids  	 NNP	B-NP
were  	were  	 VBD	O
the  	the  	 DT	O
main  	main  	 JJ	O
treatment  	treatment  	 NN	O
in  	in  	 IN	O
93 	93 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
alone  	alone  	 RB	O
( 	( 	 -LRB-	O
9 	9 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
in  	in  	 IN	O
combination  	combination  	 NN	O
with  	with  	 IN	O
immunosuppressive  	immunosuppressive  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
( 	( 	 -LRB-	O
84 	84 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Most  	Most  	 RBS	O
frequently  	frequently  	 RB	O
preferred  	preferred  	 VBN	O
immunosuppressive  	immunosuppressive  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
were  	were  	 VBD	O
methotrexate  	methotrexate  	 NNS	B-NP
( 	( 	 -LRB-	O
63 	63 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
azathioprine  	azathioprine  	 NNS	B-NP
( 	( 	 -LRB-	O
22 	22 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
cyclophosphamide  	cyclophosphamide  	 NNS	B-NP
( 	( 	 -LRB-	O
13 	13 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Remission  	Remission  	 NNP	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
at  	at  	 IN	O
least  	least  	 JJS	O
once  	once  	 RB	O
in  	in  	 IN	O
94 	94 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
and  	and  	 CC	O
sustained  	sustained  	 VBD	B-NP
remission  	remission  	 VBN	I-NP
in  	in  	 IN	O
71 	71 	 CD	O
%  	%  	 NN	O
during  	during  	 IN	O
follow-up 	follow-up 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
demographical 	demographical 	 NN	B-NP
,  	,  	 ,	O
clinical  	clinical  	 JJ	O
and  	and  	 CC	O
angiographic  	angiographic  	 JJ	B-NP
findings  	findings  	 NNS	I-NP
of  	of  	 IN	I-NP
TA  	TA  	 NNP	I-NP
patients  	patients  	 NNS	I-NP
in  	in  	 IN	O
our  	our  	 PRP$	O
series  	series  	 NN	O
were  	were  	 VBD	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
those  	those  	 DT	O
reported  	reported  	 VBN	O
from  	from  	 IN	O
Japan 	Japan 	 NNP	O
,  	,  	 ,	O
Brazil  	Brazil  	 NNP	O
and  	and  	 CC	O
Colombia 	Colombia 	 NNP	B-NP
.  	.  	 .	O
Combination  	Combination  	 NN	B-NP
therapies  	therapies  	 NNS	I-NP
with  	with  	 IN	O
immunosuppressive  	immunosuppressive  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
were  	were  	 VBD	O
the  	the  	 DT	O
preferred  	preferred  	 JJ	O
choice  	choice  	 NN	O
of  	of  	 IN	O
treatment  	treatment  	 NN	O
in  	in  	 IN	O
Turkey 	Turkey 	 NNP	O
.  	.  	 .	O
